"Difficult Quarter": HIMS Plunges On Weak GLP-1 Sales

zerohedge.com/markets/difficult-quarter-hims-plunges-weak-glp-1-sales

"Difficult Quarter": HIMS Plunges On Weak GLP-1 Sales

Hims & Hers Health (HIMS), the telehealth platform known for selling compounded GLP-1 weight-loss drugs, tumbled in premarket trading in New York after missing Wall Street's revenue estimates in its Monday after-hours earnings…

This story appeared on zerohedge.com, 2025-08-05 11:20:00.
The Entire Business World on a Single Page. Free to Use →